As of 2026-05-30, the Intrinsic Value of Dice Therapeutics Inc (DICE) is -9.51 USD. This DICE valuation is based on the model Peter Lynch Fair Value. With the current market price of 47.55 USD, the upside of Dice Therapeutics Inc is -120.01%.
Based on its market price of 47.55 USD and our intrinsic valuation, Dice Therapeutics Inc (DICE) is overvalued by 120.01%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -9.51 - -9.51 | -9.51 | -120.01% |
| P/E | (37.72) - (34.56) | (38.39) | -180.7% |
| DDM - Stable | (19.73) - (67.29) | (43.51) | -191.5% |
| DDM - Multi | (16.71) - (44.61) | (24.35) | -151.2% |
| Market Cap (mil) | 2,272.42 |
| Beta | 0.56 |
| Outstanding shares (mil) | 47.79 |
| Enterprise Value (mil) | 2,170.83 |
| Market risk premium | 4.60% |
| Cost of Equity | 8.65% |
| Cost of Debt | 5.00% |
| WACC | 6.16% |